Data Foundry

Drug recalls 2014

TOPIRAMATE Tablets 200 mg — Class II drug recall D-0015-2015

Terminated recall by Zydus Pharmaceuticals USA Inc, reported 2014-10-22, distributed nationwide. Presence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets.

Recall numberD-0015-2015
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmZydus Pharmaceuticals USA Inc, Pennington, NJ, United States
Recall initiated2014-09-15
Classified2014-10-10
Reported by FDA2014-10-22
Terminated2017-09-20
DistributedNationwide (US)
Quantity14,568 bottles
NDC68382-0138, 68382-0138-01, 68382-0138-05, 68382-0138-14, 68382-0138-16, 68382-0139, 68382-0139-01, 68382-0139-05, 68382-0139-14, 68382-0139-16, 68382-0140, 68382-0140-01, 68382-0140-05, 68382-0140-14, 68382-0140-16, 68382-0141, 68382-0141-01, 68382-0141-05, 68382-0141-14, 68382-0141-16
Lot numbersMN9828
Expiration dates2015-10-20

Product

TOPIRAMATE Tablets 200 mg, 60 Tablet Bottles, Rx Only. Manufactured by Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ USA 08534. NDC 68382-141-14.

Reason for recall

Presence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0015-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.